Celltrion’s Rituximab Biosimilar Is The First Greenlit By The FDA

 
• By Dean Rudge
  
Traffic light
FDA gives Truxima the green light
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products